Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 15

Difference in Gastrointestinal Risk Associated with Use of GLP-1 Receptor Agonists: A Real-World Pharmacovigilance Study

Total article views   HTML views PDF downloads Totals
11,805 Dovepress* 7,067+ 540 7,607
PubMed Central* 4,738 482 5,220
Totals 11,805 1,022 12,827
*Since 13 January 2022
Total mentioned Facebook Delicious Reddit Twitter Others
12 0 0 0 0 12

View citations on PubMed and Google Scholar